Tipifarnib in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome in Complete Remission - Related Studies

Tipifarnib in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome in Complete Remission

This study has been completed.

Study NCT00045396. Last updated on August 22, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Leukemia
		Myelodysplastic Syndromes

2	Additional conditions recognized in this trial
		Leukemia, Myeloid
		Leukemia, Myeloid, Acute
		Preleukemia
		Syndrome

3	More general conditions related to this trial
		Bone Marrow Diseases
		Disease
		Hematologic Diseases
		Neoplasms
		Neoplasms by Histologic Type
		Pathologic Processes
		Precancerous Conditions

4	Interventions listed in this trial
		tipifarnib

5	More general drug interventions related to this trial
		Antineoplastic Agents
		Pharmacologic Actions
		Therapeutic Uses

6	Sponsors listed in this trial
		Sidney Kimmel Comprehensive Cancer Center
		National Cancer Institute (NCI)